Total Payments
$1,765
2024 Payments
$559.86
Companies
34
Transactions
80
Medicare Patients
91
Medicare Billing
$9,690
Payment Breakdown by Category
Food & Beverage$1,765 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,765 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $316.08 | 5 | $0 (2024) |
| Novo Nordisk Inc | $191.86 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $182.28 | 10 | $0 (2024) |
| PFIZER INC. | $159.21 | 4 | $0 (2024) |
| ABBVIE INC. | $78.79 | 4 | $0 (2024) |
| Lilly USA, LLC | $74.87 | 5 | $0 (2024) |
| Amgen Inc. | $68.24 | 4 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $66.66 | 2 | $0 (2022) |
| Grifols USA, LLC | $60.08 | 3 | $0 (2024) |
| Boston Scientific Corporation | $41.36 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.86 | 29 | Otsuka America Pharmaceutical, Inc. ($111.33) |
| 2023 | $303.72 | 17 | Otsuka America Pharmaceutical, Inc. ($70.95) |
| 2022 | $533.74 | 30 | Novo Nordisk Inc ($102.40) |
| 2019 | $97.12 | 1 | PFIZER INC. ($97.12) |
| 2017 | $270.81 | 3 | Merck Sharp & Dohme Corporation ($270.81) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Pulmonology | ||||||
| 11/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: VACCINE | ||||||
| 08/21/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: CNS | ||||||
| 08/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardio-renal | ||||||
| 08/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Inflammation | ||||||
| 06/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| Category: Insulin Pump | ||||||
| 06/06/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Pulmonology | ||||||
| 06/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: VACCINE | ||||||
| 04/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 31 | $3,542 | $1,595 |
| 2022 | 1 | 14 | 33 | $2,805 | $1,453 |
| 2021 | 1 | 27 | 65 | $5,525 | $3,263 |
| 2020 | 1 | 33 | 81 | $6,885 | $3,379 |
Total Patients
91
Total Services
210
Medicare Billing
$9,690
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 31 | $3,542 | $1,595 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 33 | $2,805 | $1,453 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 65 | $5,525 | $3,263 | 59.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 81 | $6,885 | $3,379 | 49.1% |
About Dr. Thomas Jamieson, D.O
Dr. Thomas Jamieson, D.O is a Sports Medicine healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538220561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Jamieson, D.O has received a total of $1,765 in payments from pharmaceutical and medical device companies, with $559.86 received in 2024. These payments were reported across 80 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($1,765).
As a Medicare-enrolled provider, Jamieson has provided services to 91 Medicare beneficiaries, totaling 210 services with total Medicare billing of $9,690. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Lansing, MI
- Active Since 12/13/2006
- Last Updated 03/19/2025
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1538220561
Products in Payments
- REXULTI (Drug) $196.05
- BELSOMRA (Drug) $180.10
- Ozempic (Drug) $108.27
- COLOGUARD (Device) $97.12
- JANUVIA (Drug) $90.71
- HETLIOZ (Drug) $66.66
- ELIQUIS (Drug) $62.09
- Prolastin-C Liquid (Biological) $60.08
- GARDASIL (Biological) $45.27
- Tymlos (Drug) $37.27
- XYOSTED (Drug) $35.68
- Auvelity (Drug) $34.95
- VRAYLAR (Drug) $32.19
- EMGALITY (Drug) $30.68
- Kerendia (Drug) $28.60
- Saxenda (Drug) $28.55
- Otezla (Drug) $28.32
- MOUNJARO (Drug) $28.07
- QULIPTA (Drug) $27.21
- VIVITROL (Drug) $26.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.